Global Antibody Drug Conjugates (ADCs) Market Professional Survey Report 2019

Publisher Name :
Date: 19-Sep-2019
No. of pages: 110
Inquire Before Buying

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.

Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.

The global Antibody Drug Conjugates (ADCs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Antibody Drug Conjugates (ADCs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Drug Conjugates (ADCs) market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Antibody Drug Conjugates (ADCs) in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Antibody Drug Conjugates (ADCs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

- Roche

- Pfizer

- Novartis

- Genmab

- Bayer

- Seattle Genetics

- Takeda Pharmaceuticals

- AbbVie

- AbGenomics

- ADC Therapeutics

- Astellas Pharma

- Kairos Therapeutics

Segment by Regions

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Segment by Type

- Seattle Genetics Technology

- ImmunoGen Technology

- Immunomedics Technology

Segment by Application

- Hospital

- Clinics

- Others

Global Antibody Drug Conjugates (ADCs) Market Professional Survey Report 2019

Table of Contents
Executive Summary
1 Industry Overview of Antibody Drug Conjugates (ADCs)
1.1 Definition of Antibody Drug Conjugates (ADCs)
1.2 Antibody Drug Conjugates (ADCs) Segment by Type
1.2.1 Global Antibody Drug Conjugates (ADCs) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Seattle Genetics Technology
1.2.3 ImmunoGen Technology
1.2.4 Immunomedics Technology
1.3 Antibody Drug Conjugates (ADCs) Segment by Applications
1.3.1 Global Antibody Drug Conjugates (ADCs) Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Antibody Drug Conjugates (ADCs) Overall Market
1.4.1 Global Antibody Drug Conjugates (ADCs) Revenue (2014-2025)
1.4.2 Global Antibody Drug Conjugates (ADCs) Production (2014-2025)
1.4.3 North America Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
1.4.4 Europe Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
1.4.5 China Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
1.4.6 Japan Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
1.4.7 Southeast Asia Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
1.4.8 India Antibody Drug Conjugates (ADCs) Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugates (ADCs)
2.3 Manufacturing Process Analysis of Antibody Drug Conjugates (ADCs)
2.4 Industry Chain Structure of Antibody Drug Conjugates (ADCs)
3 Development and Manufacturing Plants Analysis of Antibody Drug Conjugates (ADCs)
3.1 Capacity and Commercial Production Date
3.2 Global Antibody Drug Conjugates (ADCs) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Antibody Drug Conjugates (ADCs)
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Antibody Drug Conjugates (ADCs) Production and Capacity Analysis
4.2 Antibody Drug Conjugates (ADCs) Revenue Analysis
4.3 Antibody Drug Conjugates (ADCs) Price Analysis
4.4 Market Concentration Degree
5 Antibody Drug Conjugates (ADCs) Regional Market Analysis
5.1 Antibody Drug Conjugates (ADCs) Production by Regions
5.1.1 Global Antibody Drug Conjugates (ADCs) Production by Regions
5.1.2 Global Antibody Drug Conjugates (ADCs) Revenue by Regions
5.2 Antibody Drug Conjugates (ADCs) Consumption by Regions
5.3 North America Antibody Drug Conjugates (ADCs) Market Analysis
5.3.1 North America Antibody Drug Conjugates (ADCs) Production
5.3.2 North America Antibody Drug Conjugates (ADCs) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Antibody Drug Conjugates (ADCs) Import and Export
5.4 Europe Antibody Drug Conjugates (ADCs) Market Analysis
5.4.1 Europe Antibody Drug Conjugates (ADCs) Production
5.4.2 Europe Antibody Drug Conjugates (ADCs) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Antibody Drug Conjugates (ADCs) Import and Export
5.5 China Antibody Drug Conjugates (ADCs) Market Analysis
5.5.1 China Antibody Drug Conjugates (ADCs) Production
5.5.2 China Antibody Drug Conjugates (ADCs) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Antibody Drug Conjugates (ADCs) Import and Export
5.6 Japan Antibody Drug Conjugates (ADCs) Market Analysis
5.6.1 Japan Antibody Drug Conjugates (ADCs) Production
5.6.2 Japan Antibody Drug Conjugates (ADCs) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Antibody Drug Conjugates (ADCs) Import and Export
5.7 Southeast Asia Antibody Drug Conjugates (ADCs) Market Analysis
5.7.1 Southeast Asia Antibody Drug Conjugates (ADCs) Production
5.7.2 Southeast Asia Antibody Drug Conjugates (ADCs) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Antibody Drug Conjugates (ADCs) Import and Export
5.8 India Antibody Drug Conjugates (ADCs) Market Analysis
5.8.1 India Antibody Drug Conjugates (ADCs) Production
5.8.2 India Antibody Drug Conjugates (ADCs) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Antibody Drug Conjugates (ADCs) Import and Export
6 Antibody Drug Conjugates (ADCs) Segment Market Analysis (by Type)
6.1 Global Antibody Drug Conjugates (ADCs) Production by Type
6.2 Global Antibody Drug Conjugates (ADCs) Revenue by Type
6.3 Antibody Drug Conjugates (ADCs) Price by Type
7 Antibody Drug Conjugates (ADCs) Segment Market Analysis (by Application)
7.1 Global Antibody Drug Conjugates (ADCs) Consumption by Application
7.2 Global Antibody Drug Conjugates (ADCs) Consumption Market Share by Application (2014-2019)
8 Antibody Drug Conjugates (ADCs) Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Genmab
8.4.1 Genmab Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.4.2 Genmab Product Introduction, Application and Specification
8.4.3 Genmab Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer
8.5.1 Bayer Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.5.2 Bayer Product Introduction, Application and Specification
8.5.3 Bayer Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Seattle Genetics
8.6.1 Seattle Genetics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.6.2 Seattle Genetics Product Introduction, Application and Specification
8.6.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Takeda Pharmaceuticals
8.7.1 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.7.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AbbVie
8.8.1 AbbVie Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.8.2 AbbVie Product Introduction, Application and Specification
8.8.3 AbbVie Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 AbGenomics
8.9.1 AbGenomics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.9.2 AbGenomics Product Introduction, Application and Specification
8.9.3 AbGenomics Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 ADC Therapeutics
8.10.1 ADC Therapeutics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
8.10.2 ADC Therapeutics Product Introduction, Application and Specification
8.10.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Astellas Pharma
8.12 Kairos Therapeutics
9 Development Trend of Analysis of Antibody Drug Conjugates (ADCs) Market
9.1 Global Antibody Drug Conjugates (ADCs) Market Trend Analysis
9.1.1 Global Antibody Drug Conjugates (ADCs) Market Size (Volume and Value) Forecast 2019-2025
9.2 Antibody Drug Conjugates (ADCs) Regional Market Trend
9.2.1 North America Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.2.2 Europe Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.2.3 China Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.2.4 Japan Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.2.5 Southeast Asia Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.2.6 India Antibody Drug Conjugates (ADCs) Forecast 2019-2025
9.3 Antibody Drug Conjugates (ADCs) Market Trend (Product Type)
9.4 Antibody Drug Conjugates (ADCs) Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Antibody Drug Conjugates (ADCs) Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Antibody Drug Conjugates (ADCs)
Table Global Antibody Drug Conjugates (ADCs) Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Antibody Drug Conjugates (ADCs) Production Market Share by Types in 2018
Figure Seattle Genetics Technology Product Picture
Figure ImmunoGen Technology Product Picture
Figure Immunomedics Technology Product Picture
Table Global Antibody Drug Conjugates (ADCs) Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Antibody Drug Conjugates (ADCs) Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinics
Figure Others
Figure Global Antibody Drug Conjugates (ADCs) Revenue (Million USD) (2014-2025)
Figure Global Antibody Drug Conjugates (ADCs) Production (K Units) (2014-2025)
Figure North America Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Figure Europe Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Figure China Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Figure Japan Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Figure Southeast Asia Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Figure India Antibody Drug Conjugates (ADCs) Market Size (Million USD) (2014-2025)
Table Antibody Drug Conjugates (ADCs) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antibody Drug Conjugates (ADCs) in 2018
Figure Manufacturing Process Analysis of Antibody Drug Conjugates (ADCs)
Figure Industry Chain Structure of Antibody Drug Conjugates (ADCs)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Antibody Drug Conjugates (ADCs) Manufacturing Plants Distribution
Table Antibody Drug Conjugates (ADCs) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Antibody Drug Conjugates (ADCs) Capacity (K Units) of Major Manufacturers (2014-2019)
Table Antibody Drug Conjugates (ADCs) Production (K Units) of Major Manufacturers (2014-2019)
Table Antibody Drug Conjugates (ADCs) Production Market Share of Major Manufacturers (2014-2019)
Figure Antibody Drug Conjugates (ADCs) Production Share by Manufacturers in 2018
Table Antibody Drug Conjugates (ADCs) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Antibody Drug Conjugates (ADCs) Revenue Market Share of Major Manufacturers (2014-2019)
Figure Antibody Drug Conjugates (ADCs) Revenue Share by Manufacturers in 2018
Table Antibody Drug Conjugates (ADCs) Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Antibody Drug Conjugates (ADCs) Production by Regions 2014-2019 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Production Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates (ADCs) Production Market Share by Regions in 2018
Table Global Antibody Drug Conjugates (ADCs) Revenue by Regions 2014-2019 (Million USD)
Table Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates (ADCs) Revenue Market Share by Regions in 2018
Table Global Antibody Drug Conjugates (ADCs) Consumption by Regions 2014-2019 (K Units)
Table Global Antibody Drug Conjugates (ADCs) Consumption Market Share by Regions 2014-2019
Figure North America Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure North America Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table North America Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure Europe Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure Europe Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure China Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure China Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table China Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure Japan Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure Japan Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure Southeast Asia Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure India Antibody Drug Conjugates (ADCs) Production Growth Rate 2014-2019 (K Units)
Figure India Antibody Drug Conjugates (ADCs) Revenue Growth Rate 2014-2019 (Million USD)
Table India Antibody Drug Conjugates (ADCs) Production, Consumption Import and Export (K Units)
Figure Global Consumption Antibody Drug Conjugates (ADCs) Market Share by Application (2014-2019)
Figure Global Value (Consumption) Antibody Drug Conjugates (ADCs) Market Share by Application (2014-2019)
Table Roche Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Roche Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Roche Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Roche Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Roche Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Roche Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Pfizer Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Pfizer Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Pfizer Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Pfizer Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Pfizer Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Pfizer Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Novartis Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Novartis Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Novartis Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Novartis Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Novartis Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Novartis Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Genmab Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Genmab Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Genmab Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genmab Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Genmab Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Genmab Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Genmab Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Bayer Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Bayer Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Bayer Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Bayer Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Bayer Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Bayer Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Seattle Genetics Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Seattle Genetics Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table AbbVie Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table AbbVie Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table AbbVie Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table AbbVie Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure AbbVie Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table AbbVie Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table AbGenomics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table AbGenomics Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table AbGenomics Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbGenomics Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table AbGenomics Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure AbGenomics Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table AbGenomics Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Product Introduction, Application and Specification
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Production Growth Rate (2014-2019)
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Production Market Share (2014-2019)
Figure ADC Therapeutics Antibody Drug Conjugates (ADCs) Revenue Market Share (2014-2019)
Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Main Business and Markets Served
Table Astellas Pharma Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Table Kairos Therapeutics Antibody Drug Conjugates (ADCs) Production Sites and Area Served
Figure Global Antibody Drug Conjugates (ADCs) Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Antibody Drug Conjugates (ADCs) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Antibody Drug Conjugates (ADCs) Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Antibody Drug Conjugates (ADCs) Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Antibody Drug Conjugates (ADCs) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Antibody Drug Conjugates (ADCs) by Type (2019-2025)
Table Global Consumption (K Units) of Antibody Drug Conjugates (ADCs) by Application (2019-2025)
Table Antibody Drug Conjugates (ADCs) Distributors List
Table Antibody Drug Conjugates (ADCs) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs